Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • lexmano98 lexmano98 Jan 28, 2013 12:09 PM Flag

    Why has the company elected not to provide 3rd party sales info?

    Adam F is his article today stated that the company has elected not to allow 3rd party sales info to be collected and released. Why would they not allow that?

    "How will investors know if Vascepa's launch is a success?

    Amarin has decided to block wholesaler prescription data from third-party data services IMS Health and Wolters Kluwer. This makes it difficult, if not impossible, for analysts and institutional investors to measure weekly and monthly Vascepa prescriptions.

    Absent these independent data sources, investors will rely on Amarin's quarterly financial reports, and they will look to see if Vascepa sales meet Wall Street's expectations."

    I would much prefer to see the results as they occur.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.270.00(0.00%)Feb 12 4:00 PMEST